Literature DB >> 18667592

Isolation and characterization of an epidemic methicillin-resistant Staphylococcus aureus 15 variant in the central United States.

Daniel J Wolter, Archana Chatterjee, Meera Varman, Richard V Goering.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18667592      PMCID： PMC2566111          DOI： 10.1128/JCM.00985-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  21 in total

1.  Tracking methicillin-resistant Staphylococcus aureus clones during a 5-year period (1998 to 2002) in a Spanish hospital.

Authors:  Eduardo Pérez-Roth; Fabián Lorenzo-Díaz; Ninivé Batista; Antonio Moreno; Sebastián Méndez-Alvarez
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

2.  Changes in the epidemiology of meticillin-resistant Staphylococcus aureus associated with the emergence of EMRSA-16 at a university hospital.

Authors:  I Montesinos; T Delgado; D Riverol; E Salido; M A Miguel; A Jimenez; A Sierra
Journal:  J Hosp Infect       Date:  2006-09-18       Impact factor: 3.926

3.  Emergence, spread, and characterization of phage variants of epidemic methicillin-resistant Staphylococcus aureus 16 in England and Wales.

Authors:  S Murchan; H M Aucken; G L O'neill; M Ganner; B D Cookson
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

4.  Panton-Valentine leukocidin positive MRSA in 2003: the Dutch situation.

Authors:  W J B Wannet; M E O C Heck; G N Pluister; E Spalburg; M G van Santen; X W Huijsdans; E Tiemersma; A J de Neeling
Journal:  Euro Surveill       Date:  2004-11

5.  Epidemiology of emerging methicillin-resistant Staphylococcus aureus (MRSA) in Denmark: a nationwide study in a country with low prevalence of MRSA infection.

Authors:  Nuno A Faria; Duarte C Oliveira; Henrik Westh; Dominique L Monnet; Anders R Larsen; Robert Skov; Hermínia de Lencastre
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

6.  Characterisation of non-multiresistant methicillin-resistant Staphylococcus aureus (including EMRSA-15) in Kuwait Hospitals.

Authors:  E E Udo; N Al-Sweih; B Noronha
Journal:  Clin Microbiol Infect       Date:  2006-03       Impact factor: 8.067

7.  Longitudinal study of the molecular epidemiology of methicillin-resistant Staphylococcus aureus at a university hospital.

Authors:  Sabine Petersdorf; Klaus Oberdorfer; Constanze Wendt
Journal:  J Clin Microbiol       Date:  2006-10-04       Impact factor: 5.948

Review 8.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

9.  The gene for toxic shock toxin is carried by a family of mobile pathogenicity islands in Staphylococcus aureus.

Authors:  J A Lindsay; A Ruzin; H F Ross; N Kurepina; R P Novick
Journal:  Mol Microbiol       Date:  1998-07       Impact factor: 3.501

10.  Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database.

Authors:  Linda K McDougal; Christine D Steward; George E Killgore; Jasmine M Chaitram; Sigrid K McAllister; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948
View more
  7 in total

1.  Enhanced discrimination of highly clonal ST22-methicillin-resistant Staphylococcus aureus IV isolates achieved by combining spa, dru, and pulsed-field gel electrophoresis typing data.

Authors:  Anna C Shore; Angela S Rossney; Peter M Kinnevey; Orla M Brennan; Eilish Creamer; Orla Sherlock; Anthony Dolan; Robert Cunney; Derek J Sullivan; Richard V Goering; Hilary Humphreys; David C Coleman
Journal:  J Clin Microbiol       Date:  2010-03-24       Impact factor: 5.948

2.  Nasal Carriage of Epidemic Methicillin-Resistant Staphylococcus aureus 15 (EMRSA-15) Clone Observed in Three Chicago-Area Long-Term Care Facilities.

Authors:  Sanchita Das; Christopher J Anderson; Althea Grayes; Katherine Mendoza; Maureen Harazin; Donna M Schora; Lance R Peterson
Journal:  Antimicrob Agents Chemother       Date:  2013-06-24       Impact factor: 5.191

3.  The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2018/2019.

Authors: 
Journal:  EFSA J       Date:  2021-04-12

4.  Prevalence and clonality of methicillin-resistant Staphylococcus aureus (MRSA) in the Atlantic Azores islands: predominance of SCCmec types IV, V and VI.

Authors:  T Conceição; A Tavares; M Miragaia; K Hyde; M Aires-de-Sousa; H de Lencastre
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-13       Impact factor: 3.267

5.  Comparative genomic analysis of European and Middle Eastern community-associated methicillin-resistant Staphylococcus aureus (CC80:ST80-IV) isolates by high-density microarray.

Authors:  R V Goering; A R Larsen; R Skov; F C Tenover; K L Anderson; P M Dunman
Journal:  Clin Microbiol Infect       Date:  2009-06-11       Impact factor: 8.067

6.  A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus.

Authors:  Stefan Monecke; Geoffrey Coombs; Anna C Shore; David C Coleman; Patrick Akpaka; Michael Borg; Henry Chow; Margaret Ip; Lutz Jatzwauk; Daniel Jonas; Kristina Kadlec; Angela Kearns; Frederic Laurent; Frances G O'Brien; Julie Pearson; Antje Ruppelt; Stefan Schwarz; Elizabeth Scicluna; Peter Slickers; Hui-Leen Tan; Stefan Weber; Ralf Ehricht
Journal:  PLoS One       Date:  2011-04-06       Impact factor: 3.240

7.  MRSA clonal complex 22 strains harboring toxic shock syndrome toxin (TSST-1) are endemic in the primary hospital in Gaza, Palestine.

Authors:  Nahed Al Laham; José R Mediavilla; Liang Chen; Nahed Abdelateef; Farid Abu Elamreen; Christine C Ginocchio; Denis Pierard; Karsten Becker; Barry N Kreiswirth
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.